Organon & Co. (OGN)
13.66
+0.01
(+0.07%)
USD |
NYSE |
Sep 15, 16:00
13.69
+0.03
(+0.22%)
Pre-Market: 08:08
Organon Debt to Equity Ratio : 8.502 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.502 |
| March 31, 2026 | 9.490 |
| December 31, 2025 | 11.70 |
| September 30, 2025 | 9.744 |
| June 30, 2025 | 12.14 |
| March 31, 2025 | 16.52 |
| December 31, 2024 | 19.14 |
| September 30, 2024 | 17.75 |
| June 30, 2024 | 60.11 |
| March 31, 2024 | 181.54 |
| December 31, 2023 | -127.59 |
| September 30, 2023 | -14.69 |
| Date | Value |
|---|---|
| June 30, 2023 | -15.73 |
| March 31, 2023 | -11.82 |
| December 31, 2022 | -10.22 |
| September 30, 2022 | -8.160 |
| June 30, 2022 | -7.822 |
| March 31, 2022 | -7.275 |
| December 31, 2021 | -6.210 |
| September 30, 2021 | -5.925 |
| June 30, 2021 | -4.985 |
| March 31, 2021 | 0.2046 |
| December 31, 2020 | 0.0057 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Merck & Co., Inc. | 1.286 |
| Eli Lilly & Co. | 1.621 |
| Pfizer Inc. | 0.7418 |
| Bristol Myers Squibb Co. | 2.019 |
| Crinetics Pharmaceuticals, Inc. (DELISTED) | 0.0396 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 13.18B |
| Total Liabilities (Quarterly) | 12.17B |
| Shareholders Equity (Quarterly) | 1.006B |
| Current Ratio | 1.954 |
| Net Debt Paydown Yield | 2.27% |